Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Tags:
Eli Lilly, abemaciclib, advanced breast cancer, Incyte, epacadostat, Imbruvica, JNJ, prostate cancer
Eli Lilly: Can Sales Grow Without M&A?
Barron's
Sat, 08/19/17 - 10:31 am
Tags:
Eli Lilly, M&A
Eli Lilly’s odyssey to use a fake rule and fake news to protect bad patents
Stat
Wed, 08/16/17 - 11:11 am
Tags:
Eli Lilly, patents, Canada, NAFTA, Strattera, Zyprexa
The 2017 report card so far: Big Biotech largely trading up as pharma posts mixed results
Fierce Pharma
Thu, 08/10/17 - 06:58 pm
Tags:
pharma stocks, Merck, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, GSK, Roche, Sanofi, Bayer, Novo Nordisk, Celgene, Biogen, AstraZeneca
Lilly's turn to pain gathers momentum
BioPharma Dive
Mon, 08/7/17 - 11:30 am
Tags:
Eli Lilly, Lasmiditan, migraines
Lilly's acute migraine drug succeeds in late-stage study
Yahoo/Reuters
Fri, 08/4/17 - 11:35 am
Tags:
Eli Lilly, migraines, clinical trials, Lasmiditan
CVS formulary knocks Lilly, BI's Jardiance in favor of J&J's Invokana
Fierce Pharma
Wed, 08/2/17 - 11:57 am
Tags:
formulary, Eli Lilly, Boehringer Ingelheim, JNJ, Invokana, diabetes, CVS Caremark
Radius' Tymlos gets another big break as Express Scripts boots Lilly's Forteo
Fierce Pharma
Tue, 08/1/17 - 11:49 am
Tags:
Radius Health, Tymlos, Express Scripts, PBMs, formulary, Eli Lilly, Forteo, osteoporosis
Eli Lilly CEO expects a Trump executive order on drug pricing this year
CNBC
Sat, 07/29/17 - 09:38 am
Tags:
Eli Lilly, David Ricks, Pharma CEOs, drug pricing, Donald Trump
Lilly's baricitinib setback gives Pfizer's Xeljanz a clear shot at newer rivals
Fierce Pharma
Wed, 07/26/17 - 10:33 pm
Tags:
Eli Lilly, baricitinib, Pfizer, Xeljanz, bloodthinners
Lilly, J&J, AbbVie and WuXi help seed a regenerative medicine upstart
Endpoints
Wed, 07/26/17 - 09:49 am
Tags:
Eli Lilly, JNJ, AbbVie, WuXi, regenerative medicine, Rodeo Therapeutics
Lilly puts two-thirds of midphase cancer pipeline up for sale in major shake-up of R&D priorities
Fierce Biotech
Tue, 07/25/17 - 10:27 am
Tags:
Eli Lilly, M&A, oncology, R&D
Lilly beats profit estimates, delays arthritis drug application
Yahoo/Reuters
Tue, 07/25/17 - 08:31 am
Tags:
Eli Lilly, earnings, baricitinib
Torpedoed by blood clots, Eli Lilly says a baricitinib comeback in rheumatoid arthritis could take years
Endpoints
Tue, 07/25/17 - 08:27 am
Tags:
baricitinib, Eli Lilly, blood clots, rheumatoid arthritis
Big Pharma Q2 Earnings Releases on Jul 25: LLY, BIIB, AMGN
Yahoo/Zacks.com
Mon, 07/24/17 - 11:14 am
Tags:
earnings, Eli Lilly, Biogen, Amgen
Why Eli Lilly Expects 2Q17 Revenue Growth
Market Realist
Mon, 07/24/17 - 11:10 am
Tags:
Eli Lilly, earnings
Eli Lilly offers $400M-plus deal to bag an early-stage autoimmune drug from Nektar
Endpoints
Mon, 07/24/17 - 10:46 am
Tags:
Eli Lilly, autoimmune disease, NKTR-358, Nektar
These 5 Drugs Could Be Worth $45 Billion -- and They're Not Even on the Market Yet
Motley Fool
Sun, 07/23/17 - 11:47 am
Tags:
Biogen, aducanumab, JNJ, apalutamide, Eli Lilly, abemaciclib, AbbVie, Rova-T, Celgene, ozanimod
J&J's Invokana continues downward market-share spiral as Lilly, BI's Jardiance advances
Fierce Pharma
Wed, 07/19/17 - 07:47 pm
Tags:
JNJ, Invokana, Eli Lilly, Boehringer Ingelheim, Jardiance, diabetes
Eli Lilly buys itself an antibody R&D platform from Tillman Gerngross’s Adimab
Endpoints
Wed, 07/19/17 - 09:28 am
Tags:
Eli Lilly, R&D, antibodies, Adimab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.